Come True Biomedical Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced sales was TWD 25.085 million compared to TWD 26.741 million a year ago. Operating loss was TWD 10.365 million compared to TWD 11.943 million a year ago. Net loss was TWD 5.575 million compared to TWD 31.494 million a year ago. Basic loss per share was TWD 0.18 compared to TWD 0.99 a year ago. For the half year, sales was TWD 45.597 million compared to TWD 53.497 million a year ago. Operating loss was TWD 28.413 million compared to TWD 22.539 million a year ago. Net loss was TWD 19.755 million compared to TWD 40.405 million a year ago. Basic loss per share was TWD 0.62 compared to TWD 1.28 a year ago.